A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...

Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...

ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in ...

Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.

Foal pneumonia is one of the leading causes of disease and death in foals, with severe cases being most commonly caused by ...

Children and teenagers are more vulnerable to meningitis than adults because their immune systems are still developing, ...

Colostrum is the first nutrient-rich fluid produced after childbirth, compositionally distinct from mature milk. Rich in proteins, fats, glycans, vitamins, minerals, and immune factors ...

A new study shows how bacteria administered to foals via feeding tubes trigger a response in respiratory immune cells.

A new review highlights sepsis-induced immunosuppression as a key driver of mortality, summarizing current research and ...

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...